MRKR — Marker Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $45.00m
- $33.67m
- $3.31m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 43.9 | 21.4 | 42.4 | 11.8 | 15.1 |
Net Total Receivables | 0.056 | 1 | 0 | 2.4 | 1.03 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 45.5 | 24.4 | 46 | 16.6 | 17.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.873 | 21.2 | 22.2 | 17.8 | — |
Other Long Term Assets | |||||
Total Assets | 46.4 | 45.6 | 68.1 | 34.4 | 17.1 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.99 | 6.4 | 12.9 | 7.78 | 3.07 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.27 | 18.3 | 24.1 | 14.8 | 3.07 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 44.1 | 27.3 | 44 | 19.6 | 14.1 |
Total Liabilities & Shareholders' Equity | 46.4 | 45.6 | 68.1 | 34.4 | 17.1 |
Total Common Shares Outstanding |